GROUP ONE TRADING, L.P. - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 193 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2020. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q3 2023$202,955
-41.5%
5,693
-34.2%
0.00%0.0%
Q1 2023$346,785
+3052.6%
8,648
+6552.3%
0.00%
Q4 2021$11,000
+266.7%
130
+333.3%
0.00%
Q3 2021$3,000
-96.5%
30
-96.7%
0.00%
Q2 2021$86,000
+681.8%
901
+828.9%
0.00%
Q1 2021$11,000
+37.5%
97
-4.0%
0.00%
Q2 2020$8,000
-84.6%
101
-91.4%
0.00%
Q1 2020$52,000
+300.0%
1,178
+288.8%
0.00%
Q4 2019$13,000
+550.0%
303
+482.7%
0.00%
Q3 2019$2,000
-33.3%
520.0%0.00%
Q2 2019$3,00052
+642.9%
0.00%
Q4 2018$0
-100.0%
7
-99.2%
0.00%
-100.0%
Q2 2018$64,000
-9.9%
829
-17.8%
0.00%0.0%
Q4 2016$71,000
+129.0%
1,009
+131.4%
0.00%
Q3 2016$31,000
-89.7%
436
-92.9%
0.00%
-100.0%
Q2 2016$300,000
+59.6%
6,125
+106.0%
0.00%
+33.3%
Q1 2016$188,000
+506.5%
2,974
+315.4%
0.00%
Q4 2014$31,000
-52.3%
716
-38.0%
0.00%
-100.0%
Q3 2014$65,000
+261.1%
1,155
+188.8%
0.00%
Q2 2014$18,0004000.00%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q2 2020
NameSharesValueWeighting ↓
First Light Asset Management, LLC 437,512$31,772,0002.80%
RTW INVESTMENTS, LP 1,373,284$99,728,0002.06%
Rock Springs Capital Management LP 1,028,109$74,661,0001.88%
Privium Fund Management B.V. 112,727$8,186,0001.81%
Avidity Partners Management LP 869,000$63,107,0001.31%
SUVRETTA CAPITAL MANAGEMENT, LLC 525,100$38,133,0001.16%
Boxer Capital, LLC 200,000$14,524,0000.75%
SECTOR GAMMA AS 46,221$3,357,0000.73%
FEDERATED HERMES, INC. 3,987,728$289,589,0000.65%
EMERALD ADVISERS, LLC 223,952$16,263,0000.62%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders